Managing Hemoglobin D Trait in Pregnancy: Case Study and Implications for Maternal Health

Hemoglobin D (HbD) is an inherited variant of the common Hemoglobin A, found in various populations worldwide, with a notable presence in northwest India, especially Punjab and Gujarat. While often asymptomatic, HbD can complicate pregnancy by contributing to anemia, posing challenges for maternal care. This article explores a detailed case study of HbD diagnosis during pregnancy, highlighting management strategies and broader implications for maternal health.

Hemoglobin D trait diagnosis in pregnancy

Understanding Hemoglobin D and Its Impact on Pregnancy

Hemoglobin D arises from a genetic mutation that replaces Hemoglobin A with Hemoglobin D in red blood cells. This variant is generally benign in heterozygous carriers but can lead to mild hemolytic anemia and splenomegaly in some cases. The condition becomes more complex when combined with other hemoglobinopathies such as Hemoglobin S or beta-thalassemia.

In pregnancy, anemia is a common concern, but when linked to HbD, it requires careful monitoring. The physiological changes during pregnancy can exacerbate anemia, affecting both mother and fetus. Recognizing HbD early allows healthcare providers to tailor treatment plans that improve outcomes.

Case Description: Managing HbD Trait in Pregnancy

A patient from Eastern Haryana, with a history of three pregnancies (G3P1L1A1), was diagnosed with anemia at 13 weeks gestation. Her obstetric history included:

• First pregnancy: uneventful, delivered by cesarean section.

• Second pregnancy: spontaneous abortion.

• Current pregnancy: anemia detected with hemoglobin at 6.9 g/dl.

  
  

Ultrasound revealed mild splenomegaly, prompting further investigation. Hemoglobin electrophoresis confirmed the presence of HbD trait. The patient was counseled about the genetic risks, including the possibility of the baby inheriting homozygous HbD, which could have more severe clinical implications.

Treatment and Monitoring

The patient began oral iron therapy, which effectively raised her hemoglobin to 10.6 g/dl. Regular antenatal visits included:

• Monitoring hemoglobin levels.

• Assessing fetal growth and well-being.

• Counseling on nutrition and iron supplementation adherence.

  
  

At 40 weeks and 3 days, she was admitted for an elective lower segment cesarean section (LSCS). The procedure was successful, and both mother and baby had excellent outcomes. Postpartum care included contraceptive counseling to support future reproductive planning.

Clinical Features and Genetic Considerations of HbD

HbD can present in several forms:

• Heterozygous HbD trait: Usually asymptomatic, no treatment needed.

• Homozygous HbD: Mild hemolytic anemia, non-progressive splenomegaly.

• Compound heterozygous HbSD Punjab: Combination of HbS and HbD, can cause more significant symptoms.

  
  

The risk of passing on HbD depends on the partner’s hemoglobin status. If both parents carry HbD, there is a 25% chance the child will inherit the homozygous form, which may require medical attention.

Implications for Maternal Health and Pregnancy Management

Pregnant women with HbD trait require:

• Early diagnosis: Through routine antenatal screening or targeted testing in high-prevalence areas.

• Anemia management: Iron supplementation and monitoring to maintain adequate hemoglobin levels.

• Genetic counseling: Informing couples about inheritance patterns and risks to offspring.

• Regular fetal monitoring: To detect any growth restrictions or complications early.

  
  

Despite these precautions, most women with HbD trait experience uncomplicated pregnancies and deliveries. Awareness and education are key to preventing adverse outcomes.

The Role of Population Screening and Counseling

Population-based screening programs can identify carriers of HbD and other hemoglobinopathies, especially in regions with high prevalence. Premarital and antenatal screening combined with counseling helps couples make informed reproductive choices, reducing the incidence of affected newborns.

Healthcare systems should prioritize:

• Accessible screening services

• Training for healthcare providers on hemoglobinopathies

• Community awareness campaigns

  
  

These measures contribute to better maternal and neonatal health outcomes.

Summary and Next Steps for Healthcare Providers

Managing HbD trait in pregnancy involves a multidisciplinary approach focusing on early detection, anemia treatment, and genetic counseling. The case from Eastern Haryana demonstrates that with proper care, women with HbD can have successful pregnancies and healthy babies.

Healthcare providers should:

• Include hemoglobinopathy screening in antenatal protocols where relevant.

• Educate patients about the significance of HbD and its inheritance.

• Monitor hemoglobin levels closely and treat anemia promptly.

• Provide personalized counseling on family planning and genetic risks.

  
  

By integrating these practices, maternal health can improve, and the burden of hemoglobinopathies on future generations can be reduced.

Reference:

Chavan, K., Mahapatra, S., Purandare, N. et al. HbD Punjab: A Rare Hemoglobinopathy in Pregnancy. J Obstet Gynecol India (2026).